All News

The U.S. Food and Drug Administration recently recalled two unapproved and uncleared devices whose manufacturers claimed could treat various medical conditions. The recall was a Class 1, which means there is a reasonable probability that the use of a device will cause adverse reactions, including death.

The Pharmacy Museum Foundation of Texas is donating 4,000 pieces of pharmacy memorabilia to Feik School of Pharmacy at University of the Incarnate Word in San Antonio, Texas.

A civic group has collaborated with Georgia Power and Home Depot to provide price discounts on emergency generators to pharmacies in the community of Buckhead, Georgia.

Pharmacists shouldn't be so quick to disregard articles published in alternative medicine journals because the medicine is new or more "mystic" than traditional medicine, according to a study presented by Zara Risoldi-Cochrane, PharmD, resident at the Center for Drug Information and Evidence-based Practice, School of Pharmacy & Health Professions, Creighton University, Omaha, Nebraska.

The niches that aliskiren and nebivolol, two newly approved therapies for hypertension, will occupy in the therapeutic armamentarium for hypertension remain unknown until more outcomes data are obtained with these agents, said Stuart T. Haines, PharmD, BCPS, FASHP, professor, University of Maryland School of Pharmacy, Baltimore, in his discussion of new and emerging therapies for hypertension.

With the shifting political landscape in Congress and state legislatures across the nation, and an increased focus on health care, 2009 could be a busy year for pharmacy initiatives, according to Geralyn M. Trujillo, MPP, the director of state government affairs for the American Society of Health-System Pharmacists (ASHP).